The measure reflects the percent of patients receiving spine surgery who were formally assessed for myelopathy 90 days after surgery, using the mJOA scale. Ideally, this rate would be 100%. Surgical practices in MSSIC have rates generally ranging from 40% at the low end to 85% at the high end.